This topic contains a solution. Click here to go to the answer

Author Question: The debate over corporate moral agency hinges on which question? a. Corporate decision b. ... (Read 107 times)

Anajune7

  • Hero Member
  • *****
  • Posts: 574
The debate over corporate moral agency hinges on which question?
 
 

a. Corporate decision b. Corporate punishment
  c. Individual responsibility d. Corporate fit



Question 2

A common point of contention about corporations is
 
 

a. corporate punishment is no different from individual punishment.
  b. modern corporations no longer utilize a CID structure.
  c. philosophers and business theorists disagree whether corporations are moral agents.
  d. if corporations are moral agents, then this relieves individual human beings of any moral responsibility




Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ecox1012

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

b

Answer to Question 2

c




Anajune7

  • Member
  • Posts: 574
Reply 2 on: Jun 19, 2018
Excellent


matt95

  • Member
  • Posts: 317
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

In the ancient and medieval periods, dysentery killed about ? of all babies before they reach 12 months of age. The disease was transferred through contaminated drinking water, because there was no way to adequately dispose of sewage, which contaminated the water.

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library